Come up with a name for your new list and we'll add to it:
HemoShear Therapeutics raised a round of funding on , . Investors include
CIT GAP Funds.
HemoShear Therapeutics discovers novel biological targets and advances drug programs to treat metabolic disorders with significant unmet patient need. Its proprietary drug discovery platform, REVEAL-T…